KRAS and pancreatic intraductal papillary-mucinous neoplasm: Furthermore, PanINs and IPMNs have overlapping yet distinct genetic aberrations (e.g., KRAS mutations), while other alterations are unique to IPMNs (e.g., GNAS; genetics of IPMN is discussed below) [9,10].